Name : Anti-CD8/CD38 Antibody (FITC, PE)
Supplier : ABBEX
Price :50
SKU : GEN6922343249
| Category | Combination Antibodies |
| Target | CD8/CD38 Antibody (FITC |
| Immunogen | See techfile |
| Clonality | Monoclonal, Monoclonal |
| Raised in | Mouse, Mouse |
| Reactivity | Mouse, Rat, Human |
| Form | PE, FITC |
| Purification | Affinity purified |
| Applications | WB (for other see techfile or inquire) |
| Stock availability | Shipped within 5-12 working days |
| Storage conditions | Avoid repeated freeze/thaw cycles, Aliquot and store at -20 °, C |
| Warnings | This product is for research use only |
| Properties | FITC has a green emission that's usually collected at 530 nanometers, FITC has a high quantum yield (efficiency of energy transfer from absorption to emission fluorescence) and approximately half of the absorbed photons are emitted as fluorescent light, For fluorescent microscopy applications, This abbex Fluorescein isothiocyanate (FITC) antibody is currently after some BD antibodies the most commonly used fluorescent dye for FACS, When excited at 488 nanometers, abbex FITC is highly sensitive to pH extremes, its photo bleaching effects are not observed due to a very brief interaction at the laser intercept, the 1 FITC is seldom used as it photo bleaches rather quickly though in flow cytometry applications, the FL1 detector of a FACSCalibur or FACScan, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by abbex they should be stored frozen at - 24° |
| Description | This transmembrane glycoprotein is detected by monoclonals and has a lot of clones available with different affinity, Cytotoxic T cells cluster differentiators for flow cytometry |
| Conjugation | Anti-FITC Antibody |
| Gene target | CD8/CD38 PE) |
| Short name | PE), Anti-CD8/CD38 Antibody (FITC |
| Technique | Fluorescein, antibodies against human proteins, antibodies for, Antibody |
| Label | FITC |
| Alternative name | peroxidase), antibody to-CD8/CD38 molecule (Antibody to) (fluorecein |
| Alternative technique | antibodies |
| Alternative to gene target | ADPRC 1 and T10, CD38 and IDBG-10668 and ENSG00000004468 and 952, CD38 and IDBG-643982 and ENSBTAG00000013569 and 327677, Cd38 and IDBG-161475 and ENSMUSG00000029084 and 12494, DNA-templated and biological process this GO :0045893 and positive regulation of transcription, DNA-templated and biological process this GO :0045907 and positive regulation of vasoconstriction and biological process this GO :0050135 and NAD(P)+ nucleosidase activity and molecular function this GO :0050853 and B cell receptor signaling pathway and biological process this GO :0060292 and long term synaptic depression and biological process this GO :0070555 and response to interleukin-1 and biological process this GO :0097190 and apoptotic signaling pathway and biological process, acting on glycosyl bonds, acting on glycosyl bonds and also this GO :0016849: phosphorus-oxygen lyase activity and also this GO :0050135: NAD(P)+ nucleosidase activity, acting on glycosyl bonds and molecular function this GO :0016849 and phosphorus-oxygen lyase activity and molecular function this GO :0030307 and positive regulation of cell growth and biological process this GO :0030890 and positive regulation of B cell proliferation and biological process this GO :0032024 and positive regulation of insulin secretion and biological process this GO :0032355 and response to estradiol and biological process this GO :0032526 and response to retinoic acid and biological process this GO :0032570 and response to progesterone and biological process this GO :0033194 and response to hydroperoxide and biological process this GO :0034097 and response to cytokine and biological process this GO :0042493 and response to drug and biological process this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0043231 and intracellular membrane-bounded organelle and cellular component this GO :0045779 and negative regulation of bone resorption and biological process this GO :0045892 and negative regulation of transcription, hydrolase activity, nuclei, this GO :0001666 and response to hypoxia and biological process this GO :0003953 and NAD+ nucleosidase activity and molecular function this GO :0005634 and nucleus and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0007165 and signal transduction and biological process this GO :0007204 and positive regulation of cytosolic calcium ion concentration and biological process this GO :0007565 and female pregnancy and biological process this GO :0008152 and metabolic process and biological process this GO :0009725 and response to hormone and biological process this GO :0009986 and cell surface and cellular component this GO :0016020 and membrane and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0016740 and transferase activity and molecular function this GO :0016798 and hydrolase activity, this GO :0003953: NAD+ nucleosidase activity, this GO :0003953: NAD+ nucleosidase activity and also this GO :0016740: transferase activity and also this GO :0016798: hydrolase activity, this GO :0016740: transferase activity, this GO :0016798: hydrolase activity, this GO :0016849: phosphorus-oxygen lyase activity, this GO :0050135: NAD(P)+ nucleosidase activity, CD38 molecule |
| Identity | 1706 |
| Gene | CD8A |
| Long gene name | CD8a molecule |
| Synonyms gene | CD8 |
| Synonyms gene name | CD8 antigen, alpha polypeptide (p32) T-cell surface glycoprotein CD8 alpha chain |
| Locus | 2p11, 2 |
| Discovery year | 1986-01-01 |
| Entrez gene record | 925 |
| Pubmed identfication | 1541829 |
| RefSeq identity | NM_001768 |
| Classification | CD molecules V-set domain containing |
| Havana BLAST/BLAT | OTTHUMG00000130265 |
| Locus Specific Databases | CD8Abase: Mutation registry for CD8 deficiency LRG_44 |